Blossom Pharmaceuticals: Drug Recall
Recall #D-0210-2026 · 10/31/2025
Class II: Risk
Recall Details
- Recall Number
- D-0210-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Blossom Pharmaceuticals
- Status
- Ongoing
- Date Initiated
- 10/31/2025
- Location
- Bardej, Goa, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12150 bottles
Reason for Recall
cGMP deviations
Product Description
Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.
Distribution Pattern
USA Nationwide
Other Recalls by Blossom Pharmaceuticals
- Class II: Risk 10/31/2025
- Class II: Risk 10/31/2025
- Class II: Risk 10/31/2025
- Class II: Risk 10/31/2025
- Class II: Risk 10/31/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.